<https://www.empr.com/home/news/qutenza-approved-for-postherpetic-neuralgia-phn/#webpage>
<http://schema.org/description>
"The FDA has approved Qutenza (capsaicin patch, from NeurogesX) for the management of neuropathic pain due to postherpetic neuralgia (PHN)."
<https://www.empr.com/home/news/qutenza-approved-for-postherpetic-neuralgia-phn/>